Achieve Life Sciences (ACHV) Retained Earnings (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Retained Earnings data on file, last reported at -$270.4 million in Q1 2026.

• Quarterly Retained Earnings fell 4506666.67% year-over-year to -$270.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$270.4 million (down 4506666.67% YoY) and the FY2025 annual result came in at $10000.0, down 67.74% from the prior year.
• Retained Earnings slipped to -$270.4 million in Q1 2026, from $10000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $31000.0 in Q4 2024 to a low of -$270.4 million in Q1 2026.
• A 5-year average of -$88.0 million and a median of -$101.2 million in 2022 frame the typical range for Retained Earnings.
• The widest YoY moves for Retained Earnings: up 100.02% in 2024, down 4830550.0% in 2024.
• Tracing ACHV's Retained Earnings over 5 years: stood at $4000.0 in 2022, then plunged by 4143875.0% to -$165.8 million in 2023, then jumped by 100.02% to $31000.0 in 2024, then tumbled by 67.74% to $10000.0 in 2025, then sank by 2704040.0% to -$270.4 million in 2026.
• The last three Retained Earnings figures came in at -$270.4 million (Q1 2026), $10000.0 (Q4 2025), and $9000.0 (Q3 2025), per Business Quant data.